Broadcom stock rises as Google flags up to $185 billion in AI capex spending

Broadcom stock rises as Google flags up to $185 billion in AI capex spending

New York, February 5, 2026, 11:01 ET — Regular session

  • Shares of Broadcom climbed Thursday, building on gains from earlier premarket trading.
  • Chip stocks linked to AI data centers jumped after Alphabet unveiled its 2026 spending plan.
  • Broadcom’s next big event is its quarterly report, set for after the close on March 4.

Shares of Broadcom Inc climbed roughly 2.8% to $316.53 in late morning trading Thursday, following a close at $308.05 the day before. The stock hit a peak of $326.44 earlier but pulled back afterward.

This matters since markets see Big Tech’s budget chatter as the quickest signal for AI hardware demand. Chip suppliers have been reacting to capex news, despite some cracks showing in the broader tech rally.

Alphabet, the parent company of Google, plans to ramp up its capital expenditure to between $175 billion and $185 billion in 2026. This marks a steep increase from the $91.45 billion projected for 2025 and significantly exceeds analysts’ estimates of about $115 billion, according to LSEG data. CEO Sundar Pichai told analysts, “We are seeing our AI investments and infrastructure drive revenue and growth across the board.” 1

Broadcom sits deep in the supply chain, partnering with Google on Tensor Processing Units (TPUs), the tech giant’s own AI chips. BofA Securities estimates that Google’s TPU project makes up over 80% of Broadcom’s AI compute sales. Analysts, however, note MediaTek is emerging as a competitor as customers look to spread their supply risks. 2

Broadcom climbed roughly 4.5% in premarket action but pared gains as nerves around the broader AI sector lingered. Thomas Monteiro, senior analyst at Investing.com, noted, “Unforgiving scrutiny over AI capex continues to spook investors.” 3

Broadcom’s immediate challenge is seeing if larger budgets actually boost orders for custom silicon and networking components, beyond just the top-line figures.

Here’s the downside: ramping up custom AI chips tends to squeeze margins. Broadcom flagged this risk back in December, noting a heavier share of lower-margin custom processors might weigh on profits. CFO Kirsten Spears mentioned gross margin could slip by “about 100 basis points” quarter-on-quarter; one basis point equals 0.01 percentage point. 4

Broadcom will release its fiscal first-quarter results after the market closes on March 4, followed by a conference call at 5 p.m. ET. Investors are eager for insights on AI chip demand, networking unit shipments, and any signs of margin stabilization. 5

Stock Market Today

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Oracle stock drops nearly 5% as $20B share-sale plan lands and bond debt closes
Previous Story

Oracle stock drops nearly 5% as $20B share-sale plan lands and bond debt closes

Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action
Next Story

Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

Go toTop